tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
CHRS
Coherus Biosciences
RESEARCH TOOLSreports
Want to see CHRS full AI Analyst Report?

Coherus Biosciences (CHRS) Revenue

1,677 Followers
StatisticsMarket CapRevenue

Coherus Biosciences Revenue

Coherus Biosciences had a revenue of 12.31M in the quarter ending Mar 31, 2026, with -3.44%. This bring the company's revenue in the last twelve months to 46.88M, Decreased 11.17%. In the fiscal year ending Dec 31, 2025, Coherus Biosciences had annual revenue of 42.17M with -84.20% growth.
Revenue (ttm)
46.88M
Revenue Growth
-76.26%
P/S Ratio
5.74
Revenue/Employee
$184,965
Employees
228
Market Cap
$242.17M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
42.17M-224.79M-84.20%
Dec 31, 2024
266.96M9.72M+3.78%
Dec 31, 2023
257.24M46.20M+21.89%
Dec 31, 2022
211.04M-115.51M-35.37%
Dec 31, 2021
326.55M-149.27M-31.37%
Dec 31, 2020
475.82M119.75M+33.63%
Dec 31, 2019
356.07M354.51M+22,783.74%
Dec 31, 2018
1.56M0.00―
Dec 31, 2017
1.56M――